| (CAD) | Jul 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -8.09M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BCT.TO returned -49.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -50.8% |
| 1 year | -49.3% |
| 5 years | -99.6% |
| 10 years | -99.9% |
| All-time high | $14,048.56 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BCT.TO would be worth today ›No. BriaCell Therapeutics Corp. has not paid a dividend in the past 12 months.
BriaCell Therapeutics Corp. is part of the Healthcare sector.
BriaCell Therapeutics Corp. has a market cap of 41.93M CAD, based on the latest quote.
